Evolution-based drug discovery: antifungal also disrupts blood vessel formation
- PMID: 22927796
- PMCID: PMC3424249
- DOI: 10.1371/journal.pbio.1001380
Evolution-based drug discovery: antifungal also disrupts blood vessel formation
Conflict of interest statement
The author has declared that no competing interests exist.
Figures
Comment on
-
Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent.PLoS Biol. 2012;10(8):e1001379. doi: 10.1371/journal.pbio.1001379. Epub 2012 Aug 21. PLoS Biol. 2012. PMID: 22927795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
